{"id":"https://openalex.org/W4362486725","doi":"https://doi.org/10.1158/1940-6207.c.6543577","title":"Data from Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung Adenocarcinomas","display_name":"Data from Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung Adenocarcinomas","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362486725","doi":"https://doi.org/10.1158/1940-6207.c.6543577"},"language":"en","primary_location":{"id":"doi:10.1158/1940-6207.c.6543577","doi":"https://doi.org/10.1158/1940-6207.c.6543577","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1940-6207.c.6543577","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1940-6207.c.6543577","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023062017","display_name":"Ximing Tang","orcid":"https://orcid.org/0000-0001-6534-6852","observed_orcids":["https://orcid.org/0000-0001-6534-6852"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ximing Tang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085730704","display_name":"Marileila Varella-Garcia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marileila Varella-Garcia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090826994","display_name":"Ana C. Xavier","orcid":"https://orcid.org/0000-0002-3659-3798","observed_orcids":["https://orcid.org/0000-0002-3659-3798"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana C. Xavier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028021994","display_name":"Erminia Massarelli","orcid":"https://orcid.org/0000-0001-7798-7286","observed_orcids":["https://orcid.org/0000-0001-7798-7286"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erminia Massarelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078899300","display_name":"Natalie C. Ozburn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Natalie Ozburn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001098397","display_name":"C\u00e9sar A. Moran","orcid":"https://orcid.org/0000-0003-1158-5713","observed_orcids":["https://orcid.org/0000-0003-1158-5713"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cesar Moran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5028085268","display_name":"Ignacio Ivan Wistuba","orcid":"https://orcid.org/0000-0003-3365-6340","observed_orcids":["https://orcid.org/0000-0003-3365-6340"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ignacio I. Wistuba","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.9139999747276306},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9639999866485596},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.9039999842643738},{"id":"https://openalex.org/keywords/gene-copy-number","display_name":"gene copy number","score":0.9629999995231628},{"id":"https://openalex.org/keywords/egfr-overexpression","display_name":"EGFR overexpression","score":0.871999979019165},{"id":"https://openalex.org/keywords/egfr-phosphorylation","display_name":"EGFR phosphorylation","score":0.9570000171661377},{"id":"https://openalex.org/keywords/field-effect","display_name":"field effect","score":0.7149999737739563},{"id":"https://openalex.org/keywords/lymph-node-metastasis","display_name":"lymph node metastasis","score":0.8619999885559082},{"id":"https://openalex.org/keywords/tumor-progression","display_name":"tumor progression","score":0.9890000224113464},{"id":"https://openalex.org/keywords/chemoprevention","display_name":"chemoprevention","score":0.8339999914169312},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.9539999961853027}],"concepts":[{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.7829142808914185},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.6842473149299622},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.6399749517440796},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6125763058662415},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.509994626045227},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4979887008666992},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.49130406975746155},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.473084032535553},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.446678102016449},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.43590599298477173},{"id":"https://openalex.org/C2780849966","wikidata":"https://www.wikidata.org/wiki/Q170758","display_name":"Lymph node","level":2,"score":0.4301531910896301},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3655155301094055},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36500412225723267},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2829440236091614},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18578428030014038}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1940-6207.c.6543577","doi":"https://doi.org/10.1158/1940-6207.c.6543577","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1940-6207.c.6543577","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1940-6207.c.6543577.v1","doi":"https://doi.org/10.1158/1940-6207.c.6543577.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1940-6207.c.6543577.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1940-6207.c.6543577","doi":"https://doi.org/10.1158/1940-6207.c.6543577","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1940-6207.c.6543577","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2675416652","display_name":null,"funder_award_id":"16672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4119534169","display_name":null,"funder_award_id":"W81XWH","funder_id":"https://openalex.org/F4320306078","funder_display_name":"U.S. Department of Defense"},{"id":"https://openalex.org/G5746294","display_name":"Targeting Lung Cancer Vulnerabilities","funder_award_id":"P50CA070907","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7928453466","display_name":"IMPACT: IMAGING & MOLECULAR MARKERS FOR PATIENTS WITH LUNG CANCER: APPROACHES W/ MOLECULAR TARGETS, COMP/INNOVATIVE TREAT., THERAPEUTI MODALITIES","funder_award_id":"W81XWH0520027","funder_id":"https://openalex.org/F4320306078","funder_display_name":"U.S. Department of Defense"},{"id":"https://openalex.org/G9000878657","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","ror":"https://ror.org/0447fe631"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W117541869","https://openalex.org/W1568388409","https://openalex.org/W1642405165","https://openalex.org/W1906497903","https://openalex.org/W1984852348","https://openalex.org/W1988442083","https://openalex.org/W1992682395","https://openalex.org/W1993312546","https://openalex.org/W2005823843","https://openalex.org/W2011192758","https://openalex.org/W2014187999","https://openalex.org/W2016469173","https://openalex.org/W2030882637","https://openalex.org/W2043696829","https://openalex.org/W2069336962","https://openalex.org/W2087764235","https://openalex.org/W2094388972","https://openalex.org/W2096436433","https://openalex.org/W2106297623","https://openalex.org/W2114642822","https://openalex.org/W2126767708","https://openalex.org/W2138604360","https://openalex.org/W2140775102","https://openalex.org/W2141088968","https://openalex.org/W2142364516","https://openalex.org/W2160866033","https://openalex.org/W2167225754","https://openalex.org/W2315455232","https://openalex.org/W2319847670","https://openalex.org/W4205580080"],"related_works":["https://openalex.org/W2132506465","https://openalex.org/W2021053102","https://openalex.org/W1995315660","https://openalex.org/W2002890883","https://openalex.org/W7100803884","https://openalex.org/W2024896552","https://openalex.org/W4362486795","https://openalex.org/W1976472575","https://openalex.org/W2810381907","https://openalex.org/W6958348554"],"abstract_inverted_index":{"Abstract":[0],"To":[1],"identify":[2],"the":[3,16,43,196,216,239],"characteristics":[4],"and":[5,18,35,37,51,55,75,87,108,112,119,136,148,162,189,201,222,247],"sequence":[6],"of":[7,20,29,83,89,103,158,165,198,219,241],"epidermal":[8],"growth":[9],"factor":[10],"receptor":[11],"(EGFR)":[12],"abnormalities":[13],"relevant":[14],"to":[15,135],"pathogenesis":[17,197],"progression":[19],"lung":[21,62,199,250],"adenocarcinoma,":[22],"we":[23],"performed":[24],"a":[25,101,141],"precise":[26],"mapping":[27],"analysis":[28],"EGFR":[30,39,95,104,110,114,117,150,168,187,203,220,253],"mutation,":[31],"gene":[32,209,227],"copy":[33,105,151,210,228],"number,":[34],"total":[36],"phosphorylated":[38,113],"protein":[40,120,169,190],"expression":[41],"for":[42,238,244],"same":[44],"tissue":[45],"sites.":[46],"We":[47,181],"examined":[48],"normal":[49],"bronchial":[50],"bronchiolar":[52],"epithelium":[53],"(NBE)":[54],"tumor":[56,231],"tissues":[57],"obtained":[58],"from":[59,138,183],"50":[60],"formalin-fixed":[61],"adenocarcinomas,":[63],"including":[64],"24":[65,84],"EGFR-mutant":[66,213],"primary":[67,78,160,179],"tumors":[68,93,129,161],"with":[69,146],"nine":[70,159],"corresponding":[71],"lymph":[72],"node":[73],"metastases":[74],"26":[76,90],"wild-type":[77,92],"tumors.":[79,180],"NBE":[80,98,126,132],"in":[81,125,131,156,163,174,178,195,208,249],"12":[82],"(50%)":[85],"mutant":[86],"3":[88],"(12%)":[91],"harbored":[94],"mutations;":[96],"these":[97],"also":[99],"showed":[100],"lack":[102],"number":[106],"increase":[107,207],"frequent":[109,124],"(69%)":[111],"(33%)":[115],"overexpression.":[116],"mutation":[118,204],"overexpression":[121,170,191,221],"were":[122,153],"more":[123,223],"sites":[127,133,176],"within":[128],"than":[130,177],"adjacent":[134],"distant":[137],"tumors,":[139],"suggesting":[140],"localized":[142],"field":[143],"effect.":[144],"Sites":[145],"high":[147,226],"low":[149],"numbers":[152,229],"heterogeneously":[154],"distributed":[155,225],"six":[157],"one":[164],"eight":[166],"metastases.":[167],"was":[171],"significantly":[172],"higher":[173,217],"metastasis":[175],"conclude":[182],"our":[184],"findings":[185,234],"that":[186,202],"mutations":[188],"are":[192],"early":[193],"phenomena":[194],"adenocarcinoma":[200,214,251],"precedes":[205],"an":[206],"number.":[211],"In":[212],"metastases,":[215],"levels":[218],"homogeneously":[224],"suggest":[230],"progression.":[232],"Our":[233],"have":[235],"important":[236],"implications":[237],"development":[240],"new":[242],"strategies":[243],"targeted":[245],"chemoprevention":[246],"therapy":[248],"using":[252],"inhibitors.":[254]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2023-04-05T00:00:00"}